Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Oct 24, 2026 | Point32Health | Iron Chelating AgentsPayerPolicy · POINT32HEALTH-PMNG-29201 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Filgrastim ProductsPayerPolicy · POINT32HEALTH-PMNG-15581 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Filgrastim ProductsPayerPolicy · POINT32HEALTH-PMNG-15571 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Anti-Obesity MedicationsPayerPolicy · POINT32HEALTH-PMNG-14631 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Anti-Obesity MedicationsPayerPolicy · POINT32HEALTH-PMNG-29191 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Acid Suppressive TherapyPayerPolicy · POINT32HEALTH-PMNG-29276 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Temporomandibular Joint (TMJ) Disorder TreatmentPayerPolicy · POINT32HEALTH-MNG-29261 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Dental Procedures Requiring Hospital/Facility-Based Care for Tufts Health Direct, Tufts Health Together, RITogether, and One CarePayerPolicy · POINT32HEALTH-MNG-19371 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Continuous Glucose Monitoring and Diabetes Management Devices for Tufts Health TogetherPayerPolicy · POINT32HEALTH-MNG-19301 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Continuous Glucose Monitoring and Diabetes Management DevicesPayerPolicy · POINT32HEALTH-MNG-19291 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Xolair (omalizumab)PayerPolicy · POINT32HEALTH-MDMNG-29241 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Xgeva (denosumab) and BiosimilarPayerPolicy · POINT32HEALTH-MDMNG-14361 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Targeted Immunomodulators – Skilled AdministrationPayerPolicy · POINT32HEALTH-MDMNG-29231 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Talvey (talquetamab-tgvs)PayerPolicy · POINT32HEALTH-MDMNG-13946 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Short-Acting Colony Stimulating FactorsPayerPolicy · POINT32HEALTH-MDMNG-13756 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Respiratory Interleukins Skilled AdministrationPayerPolicy · POINT32HEALTH-MDMNG-29221 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Prolia (denosumab) and BiosimilarPayerPolicy · POINT32HEALTH-MDMNG-13486 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Omisirge (omidubicel-onlv)PayerPolicy · POINT32HEALTH-MDMNG-13376 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Omisirge (omidubicel-onlv)PayerPolicy · POINT32HEALTH-MDMNG-13386 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Medicare Part B Step TherapyPayerPolicy · POINT32HEALTH-MDMNG-29211 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Medical Benefit Step TherapyPayerPolicy · POINT32HEALTH-MDMNG-28421 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Long-Acting Colony Stimulating Factor ProductsPayerPolicy · POINT32HEALTH-MDMNG-13171 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Loargys (pegzilarginase-nbln)PayerPolicy · POINT32HEALTH-MDMNG-29251 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Kebilidi (eladocagene exuparvovec-tneq)PayerPolicy · POINT32HEALTH-MDMNG-22576 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Kebilidi (eladocagene exuparvovec-tneq)PayerPolicy · POINT32HEALTH-MDMNG-26291 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Hympavzi (marstacimab-hncq)PayerPolicy · POINT32HEALTH-MDMNG-12971 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Elrexfio (elranatamab-bcmm)PayerPolicy · POINT32HEALTH-MDMNG-12731 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Continuous Glucose Monitoring Systems: Freestyle and Dexcom ProductsPayerPolicy · POINT32HEALTH-MDMNG-12671 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Botulinum ToxinsPayerPolicy · POINT32HEALTH-MDMNG-12501 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Bevacizumab ProductsPayerPolicy · POINT32HEALTH-MDMNG-24066 | Metadata changed |
|---|
| Oct 24, 2026 | Point32Health | Avlayah (tividenofusp alfa-eknm)PayerPolicy · POINT32HEALTH-MDMNG-29621 | New policy |
|---|
| Oct 24, 2026 | HealthPartners | Port-wine stain treatment – Iowa - North Dakota - South DakotaPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046103 | Retired |
|---|
| Oct 24, 2026 | HealthPartners | Heart failure pressure sensor, implantable (i.e., CardioMEMS HF System)PayerPolicy · HEALTHPARTNERS-CC-AENTRY-046438 | Retired |
|---|
| Oct 24, 2026 | HealthPartners | Growth hormone drugs - WisconsinPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046308 | Retired |
|---|
| Oct 24, 2026 | HealthPartners | Direct-to-consumer (DTC) laboratory testingPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045888 | Retired |
|---|
| Oct 24, 2026 | HealthPartners | Cosmetic and reconstructive procedures – Iowa – North Dakota – South DakotaPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045866 | Retired |
|---|
| Oct 24, 2026 | HealthPartners | Specialty testing: toxicology and pharmacogenomics - effective 01/01/2027PayerPolicy · HEALTHPARTNERS-CC-ENTRY-232712 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Specialty testing: toxicology & pharmacogenomics - retire 12/31/2026PayerPolicy · HEALTHPARTNERS-CC-ENTRY-295912 | New policy |
|---|
| Oct 24, 2026 | HealthPartners | Residential – psychiatric residential treatment facility (PRTF) - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-295590 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Port-wine stain treatmentPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046102 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Oncology – blastic plasmacytoid dendritic cell neoplasm (BPDCN) drug therapy – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-227133 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Oncology - blastic plasmacytoid dendritic cell neoplasm (BPDCN) drug therapyPayerPolicy · HEALTHPARTNERS-CC-ENTRY-210226 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Ocrelizumab (Ocrevus) and ocrelizumab hya-ocsq (Ocrevus Zunovo) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-194059 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Ocrelizumab (Ocrevus) and ocrelizumab hya-ocsq (Ocrevus Zunovo)PayerPolicy · HEALTHPARTNERS-CC-ENTRY-193159 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Home health services – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-295913 | New policy |
|---|
| Oct 24, 2026 | HealthPartners | Home health servicesPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045950 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Cosmetic and reconstructive proceduresPayerPolicy · HEALTHPARTNERS-CC-AENTRY-046277 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Compression support garmentsPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045858 | Metadata changed |
|---|
| Oct 24, 2026 | HealthPartners | Ambulance and medical transportation - Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-295914 | New policy |
|---|
| Oct 24, 2026 | HealthPartners | Ambulance and medical transportationPayerPolicy · HEALTHPARTNERS-CC-AENTRY-045641 | Metadata changed |
|---|